A practical reference on chronic hepatitis B: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-09-10. Anything still debated is marked as such rather than presented as settled.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
== F == Favorskii reaction Favorskii rearrangement Favorskii–Babayan synthesis Fehling test Feist–Benary synthesis Fenton reaction Ferrario–Ackermann reaction Ferrier carbocyclization Ferrier rearrangement Fétizon oxidation Fiesselmann thiophene synthesis Finkelstein reaction Fischer indole synthesis Fischer oxazole synthesis Fischer peptide synthesis Fischer phenylhydrazine and oxazone reaction Fischer glycosidation Fischer–Hepp rearrangement Fischer–Speier esterification Fischer Tropsch synthesis Fleming–Tamao oxidation Flood reaction Folin–Ciocalteu reagent Formox process Forster reaction Forster–Decker method Fowler process Franchimont reaction Frankland synthesis Frankland–Duppa reaction Fráter–Seebach alkylation Free radical halogenation Freund reaction Friedel–Crafts acylation Friedel–Crafts alkylation Friedländer synthesis Fries rearrangement Fritsch–Buttenberg–Wiechell rearrangement Fujimoto–Belleau reaction Fujiwara–Moritani reaction Fukuyama coupling Fukuyama indole synthesis Fukuyama reduction
=== Non-destructive sampling protocols === Although the ammonium bicarbonate protocol should not be considered a non-destructive method, it was followed by more 'true' non-destructive methods. The first of these was the eraser protocol, first tested on parchment, but later also applied to bone. The eraser protocol is performed by rubbing a PVC eraser on a piece of parchment or bone. The friction generates triboelectric forces, which causes small particles of the sample to cling to the eraser waste. From the eraser waste collagen can then be extracted and analysed. The eraser protocol was found to work relatively well for parchment, but it is less effective on bone. Additionally, it leaves microscopic traces on the bone surface, which appear very similar to use wear traces and could be an issue for use wear analysis. A second non-destructive protocol is the plastic bag protocol, first published in 2019. It is based on the idea that the normal friction between an object and the plastic bags, commonly used for storing archaeological objects, might be sufficient to extract enough material for ZooMS analysis. A third protocol uses the same triboelectric principle. However, instead of using an eraser, this microgrid protocol employs a fine polishing film to remove very small amounts of material from a sample. The last non-destructive protocol that has been published for ZooMS is the membrane box protocol. The membrane box protocol is based on contact electrification, which is the generation of electrostatic forces due to small localised differences in charge between two objects.
== Mechanism == The main function of the SEC23A protein is to hydrolyze or break down a guanosine triphosphate (GTP) molecule bound to the SAR1A protein at the start of the COPII pathway. The energy released from the breaking of the GTP bond provides energy necessary to undergo another reaction. This triggers uncoating of the vesicle (a membrane bound carrying compartment for molecules) containing a secretory protein destined for packaging in the Golgi apparatus of the cell. Uncoating the vesicle exposes SNARE proteins which are needed for the vesicle to bind to the membrane site on the endoplasmic reticulum. A mutation in the SEC23A gene prevents the vesicle from uncoating so it will not bind to the receptor site on the endoplasmic reticulum to be released into the cytoplasm for transport to the Golgi apparatus. Thus, the vesicles will accumulate in the endoplasmic reticulum, causing it to become enlarged or distended. Ultimately, this causes the craniofacial symptoms present in patients with CLSD. This is probably due to abnormal secretion of collagen and possibly other secretory proteins which have accumulated in the endoplasmic reticulum. Collagen is responsible to for skull ossification, among other things.
== Management == No cure for Ehlers–Danlos syndrome is known, and treatment is supportive. Close monitoring of the cardiovascular system, physiotherapy, occupational therapy, and orthopedic instruments (e.g., wheelchairs, bracing, casting) may be helpful. This can help stabilize the joints and prevent injury. Orthopedic instruments are helpful for the prevention of further joint damage, especially for long distances. People should avoid activities that cause the joint to lock or overextend. A physician may prescribe casting to stabilize joints. Physicians may refer a person to an orthotist for orthotic treatment (bracing). Physicians may also consult a physical and/or occupational therapist to help strengthen muscles and teach people how to use and preserve their joints properly. Aquatic therapy promotes muscular development and coordination. With manual therapy, the joint is gently mobilized within the range of motion and/or manipulated. If conservative therapy is not helpful, surgical joint repair may be necessary. Medication to decrease pain or manage cardiac, digestive, or other related conditions may be prescribed. To decrease bruising and improve wound healing, some people have responded to vitamin C. Medical care workers often take special precautions because of the sheer number of complications that tend to arise in people with EDS. In vascular EDS, signs of chest or abdominal pain are considered trauma situations. Cannabinoids and medical marijuana have shown some efficacy in reducing pain levels. In general, medical intervention is limited to symptomatic therapy.
Sources: en.wikipedia.org
A scar (or scar tissue) is an area of fibrous tissue that replaces normal skin following an injury. Scars result from the biological process of wound repair in the skin, as well as in other organs and tissues of the body. Thus, scarring is a natural part of the healing process. With the exception of very minor lesions, every wound (for example, after an accident, disease, or surgery) results in some degree of scarring. An exception is animals with complete regeneration, which regrow tissue without scar formation. Scar tissue is composed of the same protein (collagen) as the tissue that it replaces, but the fiber composition of the protein is different; instead of a random basketweave formation of the collagen fibers found in normal tissue, in fibrosis the collagen cross-links and forms a pronounced alignment in a single direction. This collagen scar tissue alignment is usually of inferior functional quality to the normal collagen randomised alignment. For example, scars in the skin are less resistant to ultraviolet radiation, and sweat glands and hair follicles do not grow back within scar tissues. A myocardial infarction, commonly known as a heart attack, causes scar formation in the heart muscle, which leads to loss of muscular power and possibly heart failure. However, there are some tissues (e.g. bone) that can heal without any structural or functional deterioration.
== Molecular mechanisms in skin aging == Many dissimilar models have been used to explain skin aging on a molecular basis, such as the theory of cellular senescence, the reduction of the cells' DNA repair capacity, the loss of telomeres, oxidative stress, etc. It is believed that external factors cause a large portion of skin aging, while only 3% is caused by hereditary genetic influences. The following sections discuss prominent models and advancements in molecular mechanism studies related to skin aging.
== Gadolinium-153 == Gadolinium-153 has a half-life of 240.6 days and emits gamma radiation with strong peaks at 41 keV and 102 keV. It is used as a gamma ray source for X-ray absorptiometry and fluorescence, for bone density gauges for osteoporosis screening, and for radiometric profiling in the Lixiscope portable x-ray imaging system, also known as the Lixi Profiler. In nuclear medicine, it serves to calibrate the equipment needed like single-photon emission computed tomography systems (SPECT) to make x-rays. It ensures that the machines work correctly to produce images of radioisotope distribution inside the patient. This isotope is produced in a nuclear reactor from europium or enriched gadolinium. It can also detect the loss of calcium in the hip and back bones, allowing the ability to diagnose osteoporosis.
=== Marijuana legalization === President Jimmy Carter was an advocate for legalization of marijuana at the national level. Carter argued that possession of less than 28 g of marijuana should be decriminalized. Carter believed in a more treatment-based approach to the addiction problems, with softer penalties for cocaine but was as opposed to heroin as his predecessors. In a speech to Congress in 1977, Carter stated that "penalties against possession of a drug should not be more damaging to an individual than the use of the drug itself." Rather than legalization, congressional lawmakers passed a bill that would criminalize only marijuana "open to public view." Scholars would later criticize the abuse of that bill when they debated stop-and-frisk laws. In 1967, the US Supreme Court ruled in Terry v. Ohio that a "stop-and-frisk" search does not violate the Fourth Amendment if the officer executing the search bears a "reasonable suspicion" that the person being searched has committed or is about to commit a crime. As a result, "stop-and-frisk" searches became much more common during the war on drugs and were generally conducted in minority communities. "Stop-and-frisk" searches have been criticized for being disproportionately carried out against minorities as a result of racial bias, but empirical literature on that count is inconclusive. Certain authors have found that even after controlling for location and crime participation rates, blacks and Hispanics are stopped more frequently than whites.
(2026) identify bone fragments and teeth from the Pleistocene strata from the Bianfu Cave (Yunnan, China) as Denisovan remains, while Ruan et al. (2026) study archaeological remains associated with Denisovan fossils from the Bianfu Cave, interpreted as indicative of specialized hunting, expedient production of stone tools and extensive use of unmodified bones by Denisovans. Hublin et al. (2026) report the discovery of new, approximately 773,000-years-old hominin fossils from Grotte à Hominidés at Thomas Quarry I in Casablanca (Morocco), close in age to Homo antecessor but morphologically distinct from members of this species, preserving a combination of primitive and derived traits seen in Eurasian archaic hominins and in Homo sapiens. Evidence from the study of a stratified sequence of lithic assemblages ranging from Acheulian to the Middle Stone Age from the Amanzi Springs archaeological site (South Africa), indicative of emergence of the Middle Stone Age in the studied area around 230,000 years ago, is presented by Blackwood et al. (2026). Evidence of consistent and specialized extraction of hornfels for the production of stone tools between 220,000 and 110,000 years ago is reported from the Jojosi site (South Africa) by Will et al. (2026). Beyene et al. (2026) report the discovery of approximately 100,000-years-old human skeletons and Middle Stone Age artifacts from the Halibee member of the Dawaitoli Formation (Ethiopia), interpreted as preserved in a wooded depositional environment with seasonal flooding. Zimmer et al.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
The lyophilized powder is kept refrigerated at 2 to 8 degrees Celsius and protected from light. Reconstituted solutions should be used promptly. Freezing and thawing repeatedly is avoided.